Dr. Gregg Day, a renowned neurologist at Mayo Clinic and co-author of a key paper on brain health, shares insightful strategies for enhancing patients' cognitive well-being. He discusses the innovative Brain Health Initiative and its mnemonic tool 'Safest Brains' to educate clinicians on optimal neurological function. The conversation also touches on the impact of social determinants on neurologic care and the SACO Scholars Program, which fosters brain health education and leadership. This dialogue emphasizes the vital role neurologists play in advocating for comprehensive brain health.

Dr. Gregg Day, a specialist in Alzheimer's diagnostics, and Dr. Sebastian Palmqvist, an expert on cognitive conditions, delve into groundbreaking advancements in blood testing for Alzheimer's. They discuss a revolutionary blood test that boasts a 90% diagnostic accuracy and a staggering positive predictive value of 95 to 99% for patients with cognitive symptoms. This innovative approach is set to transform how Alzheimer's disease is diagnosed, offering a more precise alternative to traditional methods.

Dr. Gregg Day, a specialist in Alzheimer's diagnostics, interviews Dr. Sebastian Palmqvist, a leading researcher in blood biomarker studies for Alzheimer's. They discuss the evolution of Alzheimer’s diagnosis, highlighting the shift to blood tests for streamlined and cost-effective evaluations. The conversation covers the accuracy of these biomarkers and the challenges of integrating them into clinical practice. The duo also addresses interpreting intermediate test results and the importance of establishing trust among healthcare professionals in these innovative diagnostic tools.